News

The patent includes the use of monoclonal antibodies, including the company’s therapeutic antibody iSONEP that binds sphingosine-1-phosphate (S1P). Lpath vice president, founder, and an inventor of the granted

Indicated for patients with relapsing-remitting multiple sclerosis (RRMS), the higher dose offers subcutaneous administration of thrice a week dosing regimen. Copaxone 20mg/1mL dose is currently approved for subcutaneous

The deal will assess the Durasert technology, pSivida’s core technology system, for certain ophthalmology products of the undisclosed pharmaceutical company. The Durasert technology system is designed to deliver

The Swedish firm said that the new machine is equipped with a small mass detector and an advanced flash chromatography system into one commercially available platform. The mass

Medipak Group chairman Dr Khalid J Chowdhry was quoted by the Associated Press of Pakistan (APP) as saying that the company produces nearly 150 million units of the

Following the receipt of approval from the Investigational Review Board, the study is expected to enroll patients in the summer of 2013. University of Texas M.D. Anderson Cancer

Weight-Loss Fat Burner Patch is designed to reduce the fat content drastically in the body and to reduce the fat deposition. The fat burner patch crossed its research

The oral glucan synthase inhibitor being developed for the treatment of systemic fungal diseases completed Phase I studies and is ready to enter Phase IIb studies. Scynexis president

Formulated in cherry and grape flavors, RapiMed dissolvable pain relief remedy 80mg and 160mg tablets will be manufactured and distributed by CPI within the US and North America.